Price (delayed)
$2.26
Market cap
$81.77M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.85
Enterprise value
$196.03M
Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is
There are no recent dividends present for ARMP.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.